Update from Team Type 1 (just in)...
SACRAMENTO, May 16 - Team Type 1 - sanofi-aventis rider Laszlo Bodrogi rode in the breakaway for most of stage one at the Amgen Tour of California on Monday, putting a gap of four minutes into the peloton with three other riders until arriving at the finishing circuits around the state capitol.
After snow and ice forced the cancellation of Sunday's first stage of the race, riders were eager to get started on Monday in cloudy but mostly dry weather, and with a shortened stage that began in Nevada City, Bodrogi and three other riders quickly escaped into a breakaway after just 10km of racing in the 122km day.
"I followed the first move, and looked back to see that we were all riding well together. After a while a fourth rider joined us and the break was set. The gap was good, but our group had no real chance because this stage was very much for sprinters, and the other teams picked up speed just as the headwind hit us in the valley," said Bodrogi.
Team Type 1 - sanofi-aventis General Manager Vassili Davidenko said Bodrogi in the first breakaway of the 2011 Amgen Tour of California was a positive sign for the squad.
"The guys came here to race, and it was a source of frustration to sit in a hotel room and wait as the weather played its hand. With Laszlo in the break today Team Type 1 - sanofi-aventis could sit in the pack and wait for the sprint at the end, and keep our powder dry for later in the week as well," Davidenko said.
Team Type 1 - sanofi-aventis rider Aldo Ino Ilesic was the highest placed rider on the day, finishing 22nd in a wet sprint in downtown Sacramento.
"The rain came down for a bit right at the end of the race. It wasn't especially slippery, but the effect of so many guys trying to ride fast and brake carefully at the same time stretched the pack out like elastic. It wasn't easy to follow the wheels and the rhythm of the sprint was jumpy," Ino Ilesic said.
Team Type 1 - sanofi-aventis rider Javier Megias, who has type 1 diabetes and must monitor his blood glucose continuously and periodically take insulin to control the disease, said he started Monday's stage with a BG around 200.
"It wasn't bad today, but wasn't good either. All day I held around 240, 250, and at the end I was around 280. Normally a good day of racing is 140-160," Megias said.
Megias is a professional athlete with type 1 diabetes, a chronic disease of the autoimmune system where the pancreas stops producing the hormone insulin.
Based in Atlanta, GA, Team Type 1 is an organization of more than 120 athletes on seven squads, competing at the elite, amateur and professional level in cycling, triathlon and ultramarathon events and sharing a message of hope for people affected by diabetes.
Team Type 1 - sanofi-aventis is the men's professional cycling branch of Team Type 1, and five of the 19 riders on the squad have type 1 diabetes.
With the right technology, proper nutrition and plenty of exercise, Team Type 1 strives to bring a message of hope that people with diabetes can lead normal and even extraordinary lives.
Team Type 1 - sanofi-aventis is following the Amgen Tour of California on its website
And on Facebook
And on Twitter @teamtype1 using hashtag #ATOC